Teriparatide [Human PTH]: 2.5 Years of Exper - Study guides, Class notes & Summaries

Looking for the best study guides, study notes and summaries about Teriparatide [Human PTH]: 2.5 Years of Exper? On this page you'll find 1 study documents about Teriparatide [Human PTH]: 2.5 Years of Exper.

All 1 results

Sort by:

Teriparatide [Human PTH(1-34)]: 2.5 Years of Experience on the Use and Safety of the Drug for the Treatment of Osteoporosis

Exam (elaborations)

Teriparatide [Human PTH(1-34)]: 2.5 Years of Experience on the Use and Safety of the Drug for the Treatment of Osteoporosis
-

-

-

12

July 2024

2023/2024

A+
I N NOVEMBER 2002, the Food and Drug Administration (FDA) approved teriparatide (Forteo) for the treatment of osteoporosis. Teriparatide contains the first 34 amino acids of human PTH. We will use the term teriparatide to describe PTH(1-34) produced by recombinant DNA technology by Eli Lilly & Co. (Indianapolis, IN, USA) and marketed as Forteo. The peptide produced by any other technology will be called PTH(1-34). The approval of teriparatide came after an eventful period of preclinical...
Ariikelsey
$15.49 More Info

Teriparatide [Human PTH]: 2.5 Years of Exper - Study guides, Class notes & Summaries

Teriparatide [Human PTH(1-34)]: 2.5 Years of Experience on the Use and Safety of the Drug for the Treatment of Osteoporosis